Latest Federal Register Notices
Patient Engagement Panel Renewed for 2 Years
Federal Register notice: FDA renews for two years the charter for its Patient Engagement Advisory Committee. 01/06/2020
Pharmaceutical Science Panel Charter Renewal
Federal Register notice: FDA has renewed for another two years the charter for its Pharmaceutical Science and Clinical Pharmacology Advisory Committee. 01/06/2020
Info Collection Extension for Panel Nominations
Federal Register notice: FDA seeks comments on an information collection extension for its Advisory Committee Membership Nominations. 01/06/2020
Info Collection Extension on Special Protocols
Federal Register notice: FDA seeks comments on an information collection extension for its guidance on “Special Protocol Assessment.” 01/03/2020
Info Collection on Electronic Imports Revised
Federal Register notice: FDA seeks comments on an information collection revision for “Imports and Electronic Import Entries.” 01/03/2020
Input Sought on FDA Minority Health Priorities
Federal Register notice: FDA seeks input and comments from interested stakeholders to help it establish strategic priorities for its Office of Minority Health and Health Equity. 01/02/2020